The authors show that the inhibitor of the succinate dehydrogenase, 3-nitro
proprionic acid (3-NPA), which in high doses and with chronic administratio
n is a neurotoxin, can induce profound tolerance to focal cerebral ischemia
in the rat when administered in a single dose (20 mg/kg) 3 days before isc
hemia. Infarcts were approximately 70% and 35% smaller in the 3-NPA precond
itioned groups of permanent and transient focal cerebral ischemia, respecti
vely. This regimen of 3-NPA preconditioning neither induced necrosis, apopt
osis, or any other histologically detectable damage to the brain, nor did i
t affect behavior of the animals. 3-NPA led to an immediate (l-hour) and lo
ng-lasting (3-day) decrease in succinate dehydrogenase activity (30% reduct
ion) throughout the brain, whereas only a short metabolic impairment occurr
ed (ATP decrease of 35% within 30 minutes, recovery within 2 hours). The au
thors found that 3-NPA induces a burst of reactive oxygen species and the f
ree radical scavenger dimethylthiourea, when administered shortly before th
e 3-NPA stimulus, completely blocked preconditioning. inhibition of protein
synthesis with cycloheximide given at the time of 3-NPA administration com
pletely inhibited preconditioning. The authors were unsuccessful in showing
upregulation of mRNA for the manganese superoxide dismutase, and did not d
etect increased activities of the copper-zinc and manganese superoxide dism
utases, prototypical oxygen free radicals scavenging enzymes, after 3-NPA p
reconditioning. The authors conclude that it is possible to pharmacological
ly precondition the brain against focal cerebral ischemia, a strategy that
may in principal have clinical relevance. The data show the relevance of pr
otein synthesis for tolerance, and suggests that oxygen free radicals may b
e critical signals in preconditioning.